ACRS vs SGMO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGMO Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sangamo Therapeutics, Inc. Common Stock (SGMO) driven by superior Valuation, Growth & Margin, Options & Structure while ACRS counters with relative strength in Momentum & Technical. Fundamentally, ACRS trades at N/M Forward P/E with -1412.4% operating margin (-55.1% YoY revenue) versus SGMO at 0.4x Forward P/E and -175.5% operating margin (+88.4% YoY). In options structure, ACRS sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro) against SGMO sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | ACRS Revenue | SGMO Revenue | ACRS Op. Margin | SGMO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $10M | $0M | -516.8% | -6119.3% | ACRS |
| Q4 '25 | $10M | $60M | -1724.6% | -175.5% | SGMO |
| Q1 '26 | $10M | $10M | -1111.8% | -2215.4% | ACRS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACRS | SGMO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $620.2M | $55.9M | Larger Scale | ACRS |
| Trailing P/E Ratio Valuation | N/M | 0.4x | Lower Multiple | SGMO |
| Forward P/E Ratio Valuation | N/M | 0.4x | Lower Multiple | SGMO |
| Revenue Growth (YoY) Growth | -55.1% | +88.4% | Higher Growth | SGMO |
| Operating Margin (TTM) Profitability | -1412.4% | -175.5% | Higher Margin | SGMO |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -55.5% | -2891.8% | Higher ROE | ACRS |
| 52-Week Range Position Momentum | 32% ($2โ$7) | 9% ($0โ$1) | Stronger Trend | ACRS |
| Beta / 30D Volatility Risk Regime | 1.53ฮฒ ยท 73% Vol | 1.49ฮฒ ยท 206% Vol | Lower Realized Risk | ACRS |
| Unified Institutional Score Composite Signal | 38.7 / 100 (SELL) | 52.0 / 100 (HOLD) | Higher Composite | SGMO |